Press release
RNA Editing Market Report- Expansive Coverage on the Profit Sources
According to the latest research by InsightAce Analytic, the RNA Editing Market is valued at US$ 15.2 Bn in 2023, and it is expected to reach US$ 23.1 Bn by 2031, with a CAGR of 5.60% during the forecast period of 2024-2031.
Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/2882
RNA Editing is a molecular technique that enables cells to modify specific nucleotide sequences within RNA molecules through base substitution, insertion, or deletion. With increasing concerns surrounding the healthcare sector, the adoption of RNA Editing technologies is anticipated to rise in the coming years. Additionally, the growing prevalence of chronic diseases and disorders is expected to drive market expansion.
Advancements in CRISPR-based RNA editing technologies, along with the rapid evolution of RNA-based therapeutic applications, are further contributing to market growth. Moreover, high disposable income levels and rising investments from key industry players are creating lucrative revenue opportunities for stakeholders in the global RNA Editing market.
List of Prominent Players in the RNA Editing Market:
• QIAGEN N.V.
• ProQR Therapeutics NV
• Sirna Therapeutics, Inc.
• UniqueQuire NV
• LAVA Therapeutics N.V.
• Argenx SE
• Shape Therapeutics, Inc.
• Korro Bio, In.
• Beam Therapeutics, Inc.
• Arrowhead Pharmaceuticals, Inc.
Market Dynamics:
Drivers-
The rising prevalence of chronic diseases and genetic disorders is a key factor driving the expansion of the RNA Editing market. The increasing demand for RNA-based genome editing applications is further contributing to market growth. Additionally, the growing adoption of RNA-based therapeutics, including mRNA vaccines, RNA interference therapies, and RNA editing treatments, is expected to enhance market revenue in the coming years.
Curious About This Latest Version Of The Report? Enquiry Before Buying:
https://www.insightaceanalytic.com/enquiry-before-buying/2882
Challenges:
A primary challenge facing the RNA Editing market is the issue of off-target effects and specificity concerns, particularly in developing regions, which may hinder market expansion. The high cost of RNA Editing technologies poses another significant barrier, limiting widespread adoption. Moreover, disruptions caused by the COVID-19 pandemic, including global supply chain interruptions, economic downturns, and production halts, have affected key industry participants. The inability of distributors, suppliers, and manufacturers to operate at full capacity has further constrained market growth.
Regional Trends:
North America is expected to dominate the RNA Editing market, driven by rising cases of chronic illnesses, increasing demand for RNA-based therapies, and strong R&D investments from leading industry players. The market in this region is projected to witness a high compound annual growth rate (CAGR) in the near future. Europe also holds a substantial market share, attributed to its advanced healthcare infrastructure and growing acceptance of RNA Editing technologies. The region benefits from strategic initiatives implemented by key market players to expand their presence. Additionally, collaborations between major industry participants are expected to create further opportunities for the global RNA Editing market's expansion.
Recent Developments:
• In September 2023, Wave Life Sciences submitted a proposal for a clinical trial for WVE-006, their RNA editing candidate. Dosing for the experiment has started in the U.K. after approval. This remarkable advancement in the industry represents the first time an RNA Editing candidate has advanced to clinical trials.
Unlock Your GTM Strategy:
https://www.insightaceanalytic.com/customisation/2882
Segmentation of RNA Editing Market-
By Type of RNA
• Messenger RNA Modifications
• Transfer RNA Modification
• Ribosomal RNA Modification
By Application-
• Cancer
• Genetic Disorders
• Temporary Maladies
By Technique-
• Insertion/Deletion
• Deamination
By Region-
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• South East Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of Middle East and Africa
Get more information:
https://www.insightaceanalytic.com/report/rna-editing-market/2882
Contact us:
info@insightaceanalytic.com
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 551 226 6109
Asia: +91 79 72967118
Follow Us on LinkedIn @ bit.ly/2tBXsgS
Follow Us On Facebook @ bit.ly/2H9jnDZ
Twitter: https://twitter.com/Insightace
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain a competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets, and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.https://www.insightaceanalytic.com/images_data/148861653.JPG
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release RNA Editing Market Report- Expansive Coverage on the Profit Sources here
News-ID: 3939620 • Views: …
More Releases from Insightace Analytic Pvt Ltd.
Vascular Access Device Market is on an Upward Growth Curve
Insightace Analytics Pvt. Ltd. announces the release of a market assessment report on the "Global Vascular Access Device Market- by Product (Portal Access Needles, Implantable Ports, Sheath Introducer, IV Safety Catheters, Central Venous Catheter, Peripherally Inserted Central Catheter and Catheter Stabilization), End-User (General Anesthesia, Regional Anesthesia, Oncology, Pain Management, Adult Critical Care, Neo Critical Care and Home and Alternate Care), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."
Request for…
PD-1 and PD-L1 Inhibitors Market Report- Expansive Coverage on the Profit Source …
"PD-1 and PD-L1 Inhibitors Market" in terms of revenue was estimated to be worth $ 43.54billion in 2023 and is poised to reach $ 115.90 billion by 2031, growing at a CAGR of 12.81% from 2024 to 2031 according to a new report by InsightAce Analytic.
Request for free Sample Pages:
https://www.insightaceanalytic.com/request-sample/1115
Latest Drivers Restraint and Opportunities Market Snapshot:
Key factors influencing the PD-1 and PD-L1 inhibitors market are:
• Rising awareness
• Growing…
Molecular Diagnostics Point of Care Market Report on the Untapped Growth Opportu …
"Molecular Diagnostics Point of Care Market" in terms of revenue was estimated to be worth $2.95 billion in 2023 and is poised to reach $6.42 billion by 2031, growing at a CAGR of 10.38% from 2024 to 2031 according to a new report by InsightAce Analytic.
Get Free Sample Report @
https://www.insightaceanalytic.com/request-sample/1423
Latest Drivers Restraint and Opportunities Market Snapshot:
Key factors influencing the global Molecular Diagnostics Point of Care market are:
• Rising…
Vertical Farming Market in 2025 Detailed Study Analysis
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Vertical Farming Market- by Products (Lighting, Hydroponic components, Climate Control, and Sensors), Mechanism (Hydroponics, Aeroponics, and Aquaponics), Trends, Industry Competition Analysis, Revenue and Forecast To 2034."
According to the latest research by InsightAce Analytic, the global Vertical Farming Market Size is valued at 6.90 Billion in 2024 and is predicted to reach 50.79 Billion by the…
More Releases for RNA
Global RNA Analysis/Transcriptomics Market Report
The Global RNA Analysis / Transcriptomics Market is projected to expand at a CAGR of 12.5% during the forecast period, to hit USD 8.1 Billion by 2026, according to a recent market report compiled by Global Market Estimates. Due to the rising need for personalized medicines, the demand for RNA Analysis / Transcriptomics is expected to raise the market demand.
Browse 156 Market Data Tables and 112 Figures spread through 175…
Cancer RNA Expression Market to Reap Excessive Revenues by 2028(By sequencing te …
Worldwide cancer is one of the leading cause of death and effective way of treating it still looks unaccomplished in most parts of the world. The factors which influence the successful treatment of cancer are different depending on the stage of diagnosis, treatment availability and availability of trained healthcare professionals coupled with high economic burden of the disease. The gene expression of cancerous cells varies by cancer type and may…
Senior experts from Exicure, Roche, GSK, BioNTech RNA Pharmaceuticals & MiNA The …
With less than 4 weeks until SMi’s 10th annual RNA Therapeutics event (http://www.therapeutics-rna.com/openpr) opens its doors in London, UK next month, registration will soon be closing and delegate places are becoming increasingly limited.
Over the course of 2 focused days, attendees will be able to have an exclusive look into key developments in oligonucleotide therapeutics, mRNA technology, delivery mechanisms, and much more, led by industry leaders, scientific pioneers, and academics exploring…
RNA Therapy Improves Vision in Child Blindness, hear more about recent developme …
SMi Reports: In light of recent developments in the field of RNA Therapy, SMi’s 10th Annual RNA Therapeutics is set to deliver the latest advancements in February this year.
Leber congenital amaurosis (LCA), one of the most common causes of blindness in children, has been the subject of successful RNA therapy as researchers at the University of Pennsylvania recently published new data showing the success of the new therapy which improved…
New Confirmed Delegates & Speakers for RNA Therapeutics
SMi are thrilled to welcome Dr. James Hamilton, Vice President, Head of Clinical Development, Arrowhead Pharmaceuticals onto the speaker panel RNA Therapeutics 2018!
Dr. James Hamilton is currently responsible for all aspects of clinical trial design, implementation and execution. In this role, Dr. Hamilton managed the ARC-520 and ARC-AAT global programs through Phase 2 of development. Previously, Dr. Hamilton was Medical Director and Head of Corporate Development at Arrowhead. He led…
Introducing the 9th Annual RNA Therapeutics 2018
As the requirement for targeted solutions for chronic diseases continues to grow, the interest of pharmaceutical and biotech companies has increasingly focused towards RNA therapeutics, such that by 2020, the RNA Therapeutics Market is predicted to attain $1.2 billion.
One of the main challenges in RNA Therapeutics continues to be bridging the gap between in-vivo and in-vitro models, hear key case studies on the development on the latest delivery systems and…
